Generic Drug Product Development (eBook, PDF)
Solid Oral Dosage Forms, Second Edition
Redaktion: Shargel, Leon; Kanfer, Isadore
44,95 €
44,95 €
inkl. MwSt.
Sofort per Download lieferbar
22 °P sammeln
44,95 €
Als Download kaufen
44,95 €
inkl. MwSt.
Sofort per Download lieferbar
22 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
44,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
22 °P sammeln
Generic Drug Product Development (eBook, PDF)
Solid Oral Dosage Forms, Second Edition
Redaktion: Shargel, Leon; Kanfer, Isadore
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
In this era of increased pharmaceutical industry competition, success for generic drug companies is dependent on their ability to manufacture therapeutic-equivalent drug products in an economical and timely manner, while also being cognizant of patent infringement and other legal and regulatory concerns.Generic Drug Product Development: Solid Oral
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 6.06MB
Andere Kunden interessierten sich auch für
Generic Drug Product Development (eBook, PDF)63,95 €
Pharmaceutical Product Development (eBook, PDF)61,95 €
Isadore KanferGeneric Drug Product Development (eBook, PDF)172,95 €
Leon ShargelGeneric Drug Product Development (eBook, PDF)63,95 €
Karl G. HofbauerPharmacotherapy of Obesity (eBook, PDF)61,95 €
Chi-Jen LeeDevelopment and Evaluation of Drugs (eBook, PDF)157,95 €
Drug Delivery to the Lung (eBook, PDF)61,95 €-
-
-
In this era of increased pharmaceutical industry competition, success for generic drug companies is dependent on their ability to manufacture therapeutic-equivalent drug products in an economical and timely manner, while also being cognizant of patent infringement and other legal and regulatory concerns.Generic Drug Product Development: Solid Oral
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 397
- Erscheinungstermin: 24. Oktober 2013
- Englisch
- ISBN-13: 9781420086362
- Artikelnr.: 40345000
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 397
- Erscheinungstermin: 24. Oktober 2013
- Englisch
- ISBN-13: 9781420086362
- Artikelnr.: 40345000
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Leon Shargel, PhD is the manager and founder of Applied Biopharmaceutics, LLC, a pharmaceutical consulting firm. Dr. Shargel is also an Affiliate Professor, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, and Adjunct Associate Professor, School of Pharmacy, University of Maryland, Baltimore. He has wide experience in industry and academia and has more than 200 publications, including several leading textbooks in pharmaceutical education and the generic pharmaceutical industry. Dr. Shargel received his Ph.D. in pharmacology from the George Washington University, Medical Center, Washington, D.C., and his B.S. in pharmacy from the University of Maryland, Baltimore, MD. Isadore Kanfer, PhD is Professor and Emeritus Dean of Pharmacy, and former Head of Pharmacy and Dean of the Faculty (1999-2007), Rhodes University, Grahamstown, South Africa. Dr. Kanfer has been a visiting professor at the University of California-San Francisco and the University of North Carolina School of Pharmacy, Chapel Hill. He spent several years in the pharmaceutical industry in Canada and has written or contributed to several book chapters and more than 200 research publications and conference presentations. Dr. Kanfer received his B.Sc. in pharmacy and Ph.D. in pharmaceutics from Rhodes University, Grahamstown, South Africa.
Generic Drug Product Development and Therapeutic Equivalence. Active
Pharmaceutical Ingredients.
Analytical Methods Development and Methods Validation for Oral Solid Dosage
Forms. Experimental Formulation Development. Scale-up, Technology Transfer,
and Process Performance Qualification. Drug Stability. Quality Control and
Quality Assurance. Drug Product Performance: In Vitro. ANDA Regulatory
Approval Process. Bioequivalence and Drug Product Assessment: In Vivo.
Statistical Considerations for Establishing Bioequivalence. Outsourcing
Bioavailability and Bioequivalence Studies to Contract Research
Organizations. Postapproval Changes and Postmarketing Reporting of Adverse
Drug Experiences. The United States Pharmacopeia/National Formulary: Its
History, Organization, and Role in Harmonization. Legal and Legislative
Hurdles to Generic Drug Development, Approval, and Marketing. Index.
Pharmaceutical Ingredients.
Analytical Methods Development and Methods Validation for Oral Solid Dosage
Forms. Experimental Formulation Development. Scale-up, Technology Transfer,
and Process Performance Qualification. Drug Stability. Quality Control and
Quality Assurance. Drug Product Performance: In Vitro. ANDA Regulatory
Approval Process. Bioequivalence and Drug Product Assessment: In Vivo.
Statistical Considerations for Establishing Bioequivalence. Outsourcing
Bioavailability and Bioequivalence Studies to Contract Research
Organizations. Postapproval Changes and Postmarketing Reporting of Adverse
Drug Experiences. The United States Pharmacopeia/National Formulary: Its
History, Organization, and Role in Harmonization. Legal and Legislative
Hurdles to Generic Drug Development, Approval, and Marketing. Index.
Generic Drug Product Development and Therapeutic Equivalence. Active
Pharmaceutical Ingredients.
Analytical Methods Development and Methods Validation for Oral Solid Dosage
Forms. Experimental Formulation Development. Scale-up, Technology Transfer,
and Process Performance Qualification. Drug Stability. Quality Control and
Quality Assurance. Drug Product Performance: In Vitro. ANDA Regulatory
Approval Process. Bioequivalence and Drug Product Assessment: In Vivo.
Statistical Considerations for Establishing Bioequivalence. Outsourcing
Bioavailability and Bioequivalence Studies to Contract Research
Organizations. Postapproval Changes and Postmarketing Reporting of Adverse
Drug Experiences. The United States Pharmacopeia/National Formulary: Its
History, Organization, and Role in Harmonization. Legal and Legislative
Hurdles to Generic Drug Development, Approval, and Marketing. Index.
Pharmaceutical Ingredients.
Analytical Methods Development and Methods Validation for Oral Solid Dosage
Forms. Experimental Formulation Development. Scale-up, Technology Transfer,
and Process Performance Qualification. Drug Stability. Quality Control and
Quality Assurance. Drug Product Performance: In Vitro. ANDA Regulatory
Approval Process. Bioequivalence and Drug Product Assessment: In Vivo.
Statistical Considerations for Establishing Bioequivalence. Outsourcing
Bioavailability and Bioequivalence Studies to Contract Research
Organizations. Postapproval Changes and Postmarketing Reporting of Adverse
Drug Experiences. The United States Pharmacopeia/National Formulary: Its
History, Organization, and Role in Harmonization. Legal and Legislative
Hurdles to Generic Drug Development, Approval, and Marketing. Index.







